Meta-analysis of the Relation of Body Mass Index to Cardiovascular Outcomes in Patients Receiving Intensive

Safi U Khan1, Muhammad U Khan1, Haris Riaz2

  • 1Department of Medicine, West Virginia University, Morgantown, West Virginia.

Insights

Intensive cholesterol-lowering therapy may offer greater cardiovascular benefits for individuals with normal body mass index (BMI). Obese patients might experience reduced therapy efficacy or a true therapeutic limitation.

Area of Science:

  • Cardiology
  • Metabolic Health
  • Clinical Trials

Background:

  • The effect of body mass index (BMI) on cardiovascular outcomes during intensive low-density lipoprotein cholesterol (LDL-C) lowering therapy remains unclear.
  • Understanding this relationship is crucial for optimizing treatment strategies.

Purpose of the Study:

  • To investigate the association between BMI and cardiovascular outcomes in patients undergoing intensive LDL-C lowering therapy.
  • To compare the efficacy of more intensive versus less intensive LDL-C lowering regimens across different BMI categories.

Main Methods:

  • A meta-analysis of 29 randomized controlled trials was conducted, including data up to April 2019.
  • Therapies were categorized into more intensive (e.g., statins, PCSK9 inhibitors) and less intensive (placebo or less potent agents) LDL-C lowering.
  • Random effects meta-regressions evaluated the link between BMI and cardiovascular endpoints in 265,766 patients.

Main Results:

  • Higher BMI was associated with increased risks of cardiovascular mortality (HR 1.07), all-cause mortality (HR 1.03), myocardial infarction (HR 1.06), revascularization (HR 1.08), and major adverse cardiovascular events (MACE) (HR 1.04) per 1 kg/m² BMI increase with intensive therapy.
  • Patients with BMI <25 kg/m² demonstrated the greatest risk reduction in mortality and cardiovascular outcomes compared to those with BMI ≥30 kg/m² (p-interaction ≤0.05).

Conclusions:

  • Intensive LDL-C lowering therapy may provide greater clinical benefits for patients with normal BMI compared to those with higher BMI.
  • Potential explanations include masking of therapy efficacy by higher obese patient mortality or genuine therapeutic limitations in this group.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
281
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
525
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
545
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
170
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K